Researchers at the University of California, Los Angeles (UCLA) have pioneered a groundbreaking approach in the imaging and ...
Researchers discover how amyloid-β and tau pathologies interact to drive early neurophysiological changes and cognitive ...
The following is a summary of “Association of vascular risk factors and cerebrovascular pathology with Alzheimer disease ...
GE HealthCare’s recently acquired MIM Software division has secured an FDA clearance for a tool to help quantify the density ...
Once amyloid pathology is underway, it predicts intracellular accumulation of hyperphosphorylated tau as neurofibrillary tangles and that, in turn, predicts onset of cognitive impairment.
The approach aims to increase clinician confidence in determining amyloid plaque density - a key signifier of Alzheimer’s ...
With FDA 510(k) clearance, MIMneuro may perform positron emission tomography-based imaging analysis of amyloid plaque, GE ...
Hosted on MSN4d
The Complex Pathogenesis and Genetics of Alzheimer's DiseaseEach episode of this journey through a disease state contains both a physician guide and a downloadable/printable patient ...
IGC-AD1 demonstrates the potential to modify tau and improve spatial memory. Data supports the initiation of clinical trials ...
GE HealthCare’s MIM Software receives US FDA clearance of new Centiloid scaling tool to quantify amyloid plaque in brain imaging: Chicago Thursday, September 19, 2024, 12:00 Hrs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback